ADMA Biologics (ADMA) AGM 2024 summary

Opening remarks and agenda

• The meeting was called to order virtually, with an emphasis on inclusivity and broader stockholder participation.

• Legal and technical formalities were addressed to ensure the meeting was duly authorized.

• The agenda included the introduction of officers, directors, and the independent auditor, as well as the matters proposed for stockholder action.

Board and executive committee updates

• Directors introduced included Steven Elms, Jerrold Grossman, Bryant Fong, Lawrence Guiheen, Young Kwon, and Alison Finger.

• Caitlin Kestenberg was introduced as Chief Operating Officer and Senior Vice President, Compliance.

• Jeff Lukacsko of CohnReznick LLP was introduced as the independent registered public accounting firm representative.

Shareholder proposals

• Stockholders were asked to vote on the election of Class II directors to serve until the 2027 annual meeting.

• A proposal to ratify the appointment of CohnReznick LLP as the independent registered public accounting firm for fiscal year ending December 31, 2024, was presented.